| 0.801 0.002 (0.25%) 06-28 17:35 |
|
| Open: | 0.814 |
| High: | 0.829 |
| Low: | 0.790 |
| Pre. close: | 0.799 |
| Volume: | 27,494 |
| Avg. volume: | 215,196 |
| MA (50): | 0.869 |
| MA (200): | 0.747 |
| Year high: | 1.479 |
| Year low: | 0.285 |
| Market cap: | 49(M) |
| EPS: | -0.01 |
| PE ratio: | -80.1 |
| SELL | BUY |
| HeikinAshi: | |
| Kaufmans AMA: | |
| Chandelier (20): | |
| MA (5): | |
| MA (50): | |
| MACD (26,12,9): | |
| Slow KDJ (14,3): | |
| RSI (14): | |
| CCI (20): |
Wed, 19 Nov 2025
Advanced Therapy Medicinal Products Market CAGR Of 16.2% - Market.us
Thu, 27 Jun 2024
Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market size is set to grow by USD 2.24 billion from 2024-2028, Growing geriatric population boost the market, Technavio - PR Newswire
Wed, 28 Jun 2023
Possible mechanism of metabolic and drug resistance with L-asparaginase therapy in childhood leukaemia - Frontiers
Fri, 23 Jun 2023
Pherecydes Pharma announces the results of its Combined General Meeting of June 23, 2023 - Business Wire
Wed, 12 Apr 2023
Targeting Phage Therapy 2023 final agenda, chairpersons, and speakers are released: 51+ communication, 125+ attendees, 30+ industrials - EurekAlert!
Fri, 10 Mar 2023
Diffuse large B-cell lymphoma (DLBCL) therapeutics market size to increase by USD 2,061.88 million between 2022 and 2027; Growth driven by increasing approval of therapeutics - Technavio - PR Newswire
©NovaStocks.com | euro Stocks quote, company news, stock charts, technical analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither NovaStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: Financial Modeling Prep
Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Third parties' use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.